BridgeMD
New treatment option for Congenital Heart Disease (CHD)
Official title The Effect of Music and Musical Mobile Interventions on Pain and Physiological Parameters
ClinicalTrials.gov ID: NCT07564882
What this study is testing
- What it's testing
- Chest tube removal in infants undergoing surgery for congenital heart disease is an invasive procedure associated with significant pain and physiological stress responses. This randomized controlled trial evaluates the effects of music and musical mobile interventions on pain and physiological parameters during chest tube removal.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 2 to 12
You may be able to join if
- Infants aged 2 to 12 months
- Undergoing surgery due to congenital heart disease
- Having a single chest tube
- Not receiving mechanical ventilation support
- Parent(s) voluntarily agree to participate in the study
You likely can't join if
- Receiving mechanical ventilation support
- Administration of analgesics within 2 hours prior to chest tube removal
- Presence of a neurodevelopmental disorder
- Parent(s) do not consent to participate in the study
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 2 months to 12 months. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.